Lokesh Bhatt, Veeranjaneyulu Addepalli
Diabesity, the Obesity-Diabetes Epidemic, is one of the major global health problems. Complications associated with it resulted in serious complications and need urgent attention for new therapeutic approaches. In recent years, evidence supporting role of Matrix metalloproteinases and their inhibitors in development of diabesity associated complications are increased. Due to their role in diabesity associated complications they may be potential therapeutic targets.
